Nanoparticles provoke immune response against tumors but avoid side effects
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
Scientists track evolution of microbes on the skin’s surface
A new analysis reveals how Staphylococcus aureus gains mutations that allow it to colonize eczema patches.
Nelson Yuan-sheng Kiang, influential researcher in human hearing science, dies at 93
He conducted groundbreaking research into auditory physiology at MIT and Harvard Medical School, and was the founding director of the Eaton-Peabody Laboratories at Mass Eye and Ear.
Using language skills to bridge gaps in health care
Senior Victor Damptey brings his Spanish-speaking abilities to bear as he works toward becoming a physician-scientist.
Speeding up drug discovery with diffusion generative models
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
A shot in the arm
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
New nanoparticles can perform gene editing in the lungs
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
A novel combination therapy for treating vancomycin-resistant bacterial infections
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.
Coding for health equity
Senior Mercy Oladipo is building tools to address disparities in health care.
A new control switch could make RNA therapies easier to program
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
3 Questions: Mriganka Sur on the research origins of the first approved drug to treat Rett syndrome
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
Creating a versatile vaccine to take on Covid-19 in its many guises
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
New purification method could make protein drugs cheaper
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.
MIT-Takeda Program heads into fourth year with crop of 10 new projects
The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.
Jupneet Singh: Finding purpose through service
“I feel a great connection to my community, and I always want to find a way to give back,” says the Rhodes Scholar and Air Force ROTC wing commander.